JOINT FILING AGREEMENT
Exhibit 1
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the persons named below agrees to the joint filing of a Statement on Schedule 13D (including amendments thereto) with respect to the common stock, par value $.0001 per share, of Momenta Pharmaceuticals, Inc., a Delaware corporation.
|
DATE: December 8, 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Xxxxx Xxxxxxxx |
|
|
|
Name: Xxxxx Xxxxxxxx |
|
|
|
Title: Authorized Signatory |
|
|
|
|
|
|
By: |
/s/ Xxxxxxxxx Xxxx |
|
|
|
Name: Xxxxxxxxx Xxxx |
|
|
|
Title: Authorized Signatory |
|
|
|
|
|
|
|
|
|
|
NOVARTIS PHARMA AG | |
|
|
| |
|
|
|
|
|
|
By: |
/s/ Xxxxx Xxxx |
|
|
|
Name: Xxxxx Xxxx |
|
|
|
Title: Authorized Signatory |
|
|
|
|
|
|
By: |
/s/ Xxxx-Xxxxxxxx Xxxxx |
|
|
|
Name: Xxxx-Xxxxxxxx Xxxxx |
|
|
|
Title: Authorized Signatory |
